Vivos Therapeutics Stock Price History
| VVOS Stock | USD 2.50 0.05 1.96% |
Below is the normalized historical share price chart for Vivos Therapeutics extending back to December 11, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vivos Therapeutics stands at 2.50, as last reported on the 7th of April, with the highest price reaching 2.62 and the lowest price hitting 2.42 during the day.
If you're considering investing in Vivos Stock, it is important to understand the factors that can impact its price. Vivos Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Vivos Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vivos Therapeutics' Variance of 33.63, risk adjusted performance of (0.13), and Coefficient Of Variation of (861.59) to confirm the risk estimate we provide.
At this time, Vivos Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 6.9 M in 2025, whereas Other Stockholder Equity is likely to drop slightly above 72.2 M in 2025. . At this time, Vivos Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.03 in 2025, whereas Price Earnings Ratio is likely to drop (2.68) in 2025. Vivos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of December 2020 | 200 Day MA 3.2237 | 50 Day MA 3.5421 | Beta 7.442 |
Vivos |
Sharpe Ratio = -0.1147
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VVOS |
Estimated Market Risk
| 5.89 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vivos Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vivos Therapeutics by adding Vivos Therapeutics to a well-diversified portfolio.
Price Book 1.8881 | Enterprise Value Ebitda (0.21) | Price Sales 1.03 | Shares Float 4.6 M | Wall Street Target Price 6.05 |
Vivos Therapeutics Stock Price History Chart
There are several ways to analyze Vivos Stock price data. The simplest method is using a basic Vivos candlestick price chart, which shows Vivos Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 16, 2025 | 5.95 |
| Lowest Price | April 7, 2025 | 2.5 |
Vivos Therapeutics April 7, 2025 Stock Price Synopsis
Various analyses of Vivos Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vivos Stock. It can be used to describe the percentage change in the price of Vivos Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vivos Stock.| Vivos Therapeutics Price Rate Of Daily Change | 0.98 | |
| Vivos Therapeutics Price Action Indicator | (0.04) | |
| Vivos Therapeutics Price Daily Balance Of Power | (0.25) |
Vivos Therapeutics April 7, 2025 Stock Price Analysis
Vivos Stock Price History Data
The price series of Vivos Therapeutics for the period between Tue, Jan 7, 2025 and Mon, Apr 7, 2025 has a statistical range of 3.4 with a coefficient of variation of 19.37. The daily prices for the period are distributed with arithmetic mean of 3.86. The median price for the last 90 days is 3.72. The company experienced 1:25 stock split on 27th of October 2023.| Open | High | Low | Close | Volume | ||
04/07/2025 | 2.55 | 2.62 | 2.42 | 2.50 | ||
04/07/2025 | 2.55 | 2.62 | 2.42 | 2.50 | ||
| 04/04/2025 | 2.49 | 2.62 | 2.42 | 2.55 | 48,641 | |
| 04/03/2025 | 2.53 | 2.62 | 2.44 | 2.57 | 79,300 | |
| 04/02/2025 | 2.61 | 2.70 | 2.38 | 2.57 | 160,232 | |
| 04/01/2025 | 2.82 | 2.89 | 2.58 | 2.63 | 167,190 | |
| 03/31/2025 | 3.16 | 3.16 | 2.81 | 2.85 | 136,935 | |
| 03/28/2025 | 3.16 | 3.36 | 2.84 | 3.11 | 125,500 | |
| 03/27/2025 | 3.24 | 3.28 | 3.09 | 3.19 | 41,316 | |
| 03/26/2025 | 3.36 | 3.50 | 3.17 | 3.20 | 76,800 | |
| 03/25/2025 | 3.64 | 3.77 | 3.36 | 3.49 | 65,258 | |
| 03/24/2025 | 3.69 | 3.75 | 3.50 | 3.71 | 43,123 | |
| 03/21/2025 | 3.52 | 3.68 | 3.45 | 3.60 | 61,941 | |
| 03/20/2025 | 3.56 | 3.70 | 3.50 | 3.51 | 38,974 | |
| 03/19/2025 | 3.59 | 3.59 | 3.41 | 3.53 | 31,921 | |
| 03/18/2025 | 3.60 | 3.61 | 3.36 | 3.55 | 34,433 | |
| 03/17/2025 | 3.37 | 3.65 | 3.36 | 3.58 | 68,623 | |
| 03/14/2025 | 3.25 | 3.33 | 3.10 | 3.30 | 50,231 | |
| 03/13/2025 | 3.22 | 3.35 | 3.07 | 3.16 | 70,870 | |
| 03/12/2025 | 3.42 | 3.49 | 3.16 | 3.27 | 57,933 | |
| 03/11/2025 | 3.35 | 3.43 | 3.23 | 3.36 | 52,709 | |
| 03/10/2025 | 3.54 | 3.55 | 3.22 | 3.23 | 116,148 | |
| 03/07/2025 | 3.70 | 3.81 | 3.51 | 3.69 | 73,352 | |
| 03/06/2025 | 3.46 | 3.81 | 3.35 | 3.72 | 177,811 | |
| 03/05/2025 | 3.28 | 3.57 | 3.20 | 3.46 | 73,473 | |
| 03/04/2025 | 3.23 | 3.29 | 3.07 | 3.24 | 86,470 | |
| 03/03/2025 | 3.48 | 3.48 | 3.22 | 3.30 | 141,953 | |
| 02/28/2025 | 3.36 | 3.51 | 3.32 | 3.47 | 53,168 | |
| 02/27/2025 | 3.40 | 3.50 | 3.31 | 3.39 | 129,360 | |
| 02/26/2025 | 3.34 | 3.55 | 3.32 | 3.45 | 70,159 | |
| 02/25/2025 | 3.55 | 3.64 | 3.10 | 3.35 | 229,911 | |
| 02/24/2025 | 3.10 | 3.56 | 3.07 | 3.46 | 946,107 | |
| 02/21/2025 | 3.25 | 3.33 | 3.01 | 3.12 | 152,400 | |
| 02/20/2025 | 3.31 | 3.34 | 3.13 | 3.29 | 90,839 | |
| 02/19/2025 | 3.55 | 3.68 | 3.24 | 3.31 | 253,300 | |
| 02/18/2025 | 3.90 | 4.21 | 3.40 | 3.54 | 502,142 | |
| 02/14/2025 | 3.95 | 4.27 | 3.92 | 4.00 | 146,636 | |
| 02/13/2025 | 4.02 | 4.25 | 3.89 | 4.25 | 113,727 | |
| 02/12/2025 | 3.83 | 3.95 | 3.75 | 3.88 | 146,691 | |
| 02/11/2025 | 4.11 | 4.13 | 3.90 | 3.94 | 74,765 | |
| 02/10/2025 | 4.07 | 4.23 | 4.00 | 4.13 | 56,400 | |
| 02/07/2025 | 4.05 | 4.07 | 3.77 | 4.05 | 125,000 | |
| 02/06/2025 | 4.04 | 4.11 | 3.85 | 4.05 | 119,568 | |
| 02/05/2025 | 3.82 | 4.27 | 3.81 | 4.11 | 164,035 | |
| 02/04/2025 | 3.89 | 3.96 | 3.74 | 3.81 | 131,200 | |
| 02/03/2025 | 3.90 | 4.12 | 3.74 | 3.90 | 134,500 | |
| 01/31/2025 | 3.95 | 4.10 | 3.90 | 3.97 | 115,400 | |
| 01/30/2025 | 4.26 | 4.44 | 3.85 | 3.93 | 269,800 | |
| 01/29/2025 | 4.13 | 4.36 | 4.07 | 4.24 | 64,300 | |
| 01/28/2025 | 4.14 | 4.25 | 4.05 | 4.12 | 134,900 | |
| 01/27/2025 | 4.50 | 4.60 | 4.07 | 4.22 | 324,700 | |
| 01/24/2025 | 4.80 | 5.12 | 4.71 | 4.76 | 199,300 | |
| 01/23/2025 | 4.94 | 4.97 | 4.56 | 4.71 | 368,100 | |
| 01/22/2025 | 5.40 | 5.46 | 4.94 | 5.03 | 328,500 | |
| 01/21/2025 | 5.83 | 5.83 | 5.31 | 5.61 | 242,200 | |
| 01/17/2025 | 6.04 | 6.28 | 5.61 | 5.74 | 628,700 | |
| 01/16/2025 | 5.09 | 5.97 | 4.94 | 5.95 | 560,800 | |
| 01/15/2025 | 5.13 | 5.37 | 4.97 | 5.12 | 222,100 | |
| 01/14/2025 | 4.79 | 5.35 | 4.63 | 5.06 | 287,800 | |
| 01/13/2025 | 5.10 | 5.22 | 4.41 | 4.85 | 538,900 | |
| 01/10/2025 | 4.26 | 5.14 | 4.20 | 5.08 | 826,400 |
About Vivos Therapeutics Stock history
Vivos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vivos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vivos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vivos Therapeutics stock prices may prove useful in developing a viable investing in Vivos Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6.6 M | 6.9 M | |
| Net Loss | -18.3 M | -19.2 M |
Vivos Therapeutics Stock Technical Analysis
Vivos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Vivos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vivos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vivos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vivos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | 0.1113 | |||
| Treynor Ratio | (2.81) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.